Study identity card

RECLAIM

The Netherlands
Share
  • Disease: Post-COVID-19
  • Study type: Randomised Clinical Trial, Adaptive Platform Trial, Treatment
  • Objective: To evaluate the efficacy and safety of multiple potential treatments for Long COVID symptoms simultaneously.
  • Number of participants enrolled: 466
  • Study enrolling from

Study Data

  • Adults
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Immunomodulator
  • Colchicine
  • Metformin

Other information

Funders/Sponsors:

  • ZonMw and Stichting Long COVID,

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to